20.02.2013 Views

Bioidentical Hormones - U.S. Senate Special Committee on Aging

Bioidentical Hormones - U.S. Senate Special Committee on Aging

Bioidentical Hormones - U.S. Senate Special Committee on Aging

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

245<br />

This report addresses the state laws and regulati<strong>on</strong>s related to the five protecti<strong>on</strong>s<br />

set forth above. 2 As described more fully below, these laws and regulati<strong>on</strong>s do not<br />

provide the protecti<strong>on</strong>s offered to patients under the current or proposed provisi<strong>on</strong>s of the<br />

FDCA.<br />

FINDINGS<br />

1. Disclosure that a Product Is Compounded<br />

* Only six states require that a pharmacy disclose to the patient that the drug being<br />

dispensed is a compounded drug.<br />

In Ariz<strong>on</strong>a, pharmacists must include <strong>on</strong> the label: "a statement, symbol, designati<strong>on</strong>, or<br />

abbreviati<strong>on</strong> that the pharmaceutical product is a compounded pharmaceutical product."<br />

Ariz. Admin. Code § R4-23-410(l)(4) (2007). In Colorado, the pharmacist must include<br />

the following statement <strong>on</strong> the label of all compounded drugs: "This product was<br />

compounded by the pharmacy." 3 Colo. Code Regs. § 719- 1 (2007). In Iowa, when a<br />

compounded product is to be dispensed in place of a commercially available product, the<br />

pharmacist must inform both the prescriber and the patient that the product will be<br />

compounded. See Iowa Admin. Code r. 657-20.3(1) (2007). In Oklahoma, the<br />

pharmacist must include <strong>on</strong> the label "an appropriate designati<strong>on</strong> that this is a<br />

compounded prescripti<strong>on</strong>." Okla. Admin. Code § 535:16-10-9 (2007). In Alaska, the<br />

patient must be made aware that the compounded product will be prepared by the<br />

pharmacist. Alaska Divisi<strong>on</strong> of Corporati<strong>on</strong>s, Business and Professi<strong>on</strong>al Licensing,<br />

Pharmacy Statutes and Regulati<strong>on</strong>s, at Appendix C (2007). In Washingt<strong>on</strong>, a<br />

entrnoumded {Lg c<strong>on</strong>, be substiuted for a cor -crcially available duuig Oity witl dilc<br />

written authorizati<strong>on</strong> of both the patient and the prescriber. Wash. Admin. Code § 246-<br />

878-020(1).<br />

2. Active Ingredients Used in Compounded Drugs<br />

* The vast majority of states do not address the quality or types of active ingredients<br />

compounding pharmacists may use.<br />

* Of the fiteen states that address the issue, eleven permit the pharmacist to rely <strong>on</strong><br />

"professi<strong>on</strong>al<br />

judgment."<br />

See, e.g., Alaska Divisi<strong>on</strong> of Corporati<strong>on</strong>s, Business and Professi<strong>on</strong>al Licensure,<br />

Pharmacy Statutes and Regulati<strong>on</strong>s, at Appendix C (providing that "a pharmacist shall<br />

use the pharmacist's professi<strong>on</strong>al judgment to receive, store and use drug substances for<br />

compounding prescripti<strong>on</strong>s not foundin official compendia").<br />

2 This report reflects research performed by examining state statutes and regulati<strong>on</strong>s relating to the<br />

practice of pharmacy. Our research included searches in various databases (including WESTLAW and<br />

LEXIS), as well as review of statutory codes, administrative codes and other compilati<strong>on</strong>s published by<br />

various states and available <strong>on</strong>line.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!